Category: biotech/medical – Page 1,534
Inside Mark Zuckerberg’s plan to cure all diseases as he reveals views on death
BILLIONAIRE Mark Zuckerberg has revealed his thoughts on life and death in a recent podcast.
The Facebook founder and Meta Platforms CEO has plans to cure all diseases this century but has no desire to live forever.
Zuckerberg hasn’t had an ordinary life.
He founded Facebook when he was just 19 years old and became the youngest billionaire at just 23.
Digital Twins: The Virtual Future Of Healthcare
While advancements in healthcare have come in leaps and bounds since the 20th century, there is perhaps none more exciting than what digital twin technology could offer. The healthcare industry has the potential to be revolutionized by this application of new advancements, which will ultimately lead to improved research capabilities and patient outcomes.
Defined as the virtual representation of a physical object or system across its life cycle, a digital twin is a computer program that uses real world data to create simulations that can predict the outcomes of a product or process. A concept initially utilized by NASA in the 1960s, this technology has grown exponentially in the last decade, now further expanding into the world of healthcare.
Beginning in 2014 with The Living Heart Project headed by Dassault Systémes, healthcare research with digital twins has broadened to include organs such as the brain and lungs, as well as projects for virtual parts of the body. With these models, doctors have the potential to discover undeveloped illnesses, experiment with treatments, and improve surgical outcomes. They allow clinicians to test multiple treatments across a vast range of therapies, equipment, and interventions by comparing possible outcomes without taking any risks in terms of patient safety. Ultimately, care can become more precise, targeted, and based on the most accurate data available when digital twins are utilized.
Dr. Adam Wolfberg, MD, MPH — Chief Medical Officer, Current Health — Quality Healthcare In The Home
Is the Chief Medical Officer at Current Health (https://currenthealth.com/), a Best Buy Health company (https://healthcare.bestbuy.com/) and part of the American multinational consumer electronics retailer.
Current Health is an organization that enables the delivery of healthcare services in the home to enable healthcare organizations to deliver high-quality, patient-centric care at a lower cost. The company integrates patient-reported data with data from biosensors – including their own continuous monitoring wearable devices – to provide healthcare organizations with actionable, real-time insights into the patient’s condition. Leveraging clinical algorithms that can be tailored to the individual patient, Current Health identifies when a patient needs clinical attention, allowing organizations to manage patient care remotely or coordinate in-home care via integrated service partners. The Current Health platform brings together tele-health capabilities, patient engagement tools, and in-home connectivity to provide a single solution to manage all care in the home. Dr. Wolfberg also leads implementation and account management at the organization.
Previously, Dr Wolfberg worked in medical affairs at Ovia Health, a leading maternity and family benefits solution for employers and health plans (which was acquired by LabCorp), athenahealth (network-enabled services, mobile apps, and data-driven insights to hospitals and medical organizations) and Ariosa Diagnostics.
Dr. Wolfberg trained in OB/GYN and maternal-fetal medicine at The Johns Hopkins University School of Medicine, and has an MPH from Johns Hopkins School of Hygiene and Public Health.
Before going to medical school, Dr. Wolfberg was a print journalist. He blogs at www.adamwolfberg.com, and has written for magazines and websites including the Boston Globe Magazine, Slate.com, Huffington Post, and WSJ.com. His first book, Fragile Beginnings : Discoveries and Triumphs in the Newborn ICU, was published by Beacon Press in 2012.
UC Berkeley loses CRISPR patent case, invalidating patent rights it granted gene-editing companies developing human therapies
Ending the latest chapter in a years-long legal battle over who invented CRISPR, the U.S. Patent and Trademark Office ruled on Monday that the revolutionary genome editing technology belongs to the Broad Institute of Harvard and MIT.
The decision is a blow to the University of California and biotech companies that had licensed the technology from the university for use in developing treatments, including Intellia Therapeutics and CRISPR Therapeutics. They will now have to negotiate with the Broad Institute for the right to use CRISPR for human therapies.
Amazon’s voice assistant Alexa to start seeking doctor help
If there is no doctor in the house, Amazon’s Alexa will soon be able to summon one.
Amazon and telemedicine provider Teladoc Health are starting a voice-activated virtual care program that lets customers get medical help without picking up their phones.
The service, for health issues that aren’t emergencies, will be available around the clock on Amazon’s Echo devices. Customers can tell the voice assistant Alexa that they want to talk to a doctor, and that will prompt a call back on the device from a Teladoc physician.
Breakthrough gene-editing technology belongs to Harvard, MIT —U.S. tribunal
Feb 28 (Reuters) — A U.S. tribunal overseeing patent disputes ruled on Monday that patents on the breakthrough gene-editing technology known as CRISPR belong to Harvard University and the Massachusetts Institute of Technology.
The U.S. Patent and Trademark Office’s decision is a defeat for the University of California, Berkeley; the University of Vienna and Nobel Prize-winning researcher Emmanuelle Charpentier.
Harvard’s and MIT’s Broad Institute, which obtained the first CRISPR patent in 2014 and later obtained related patents, said the decision confirmed its patents were properly issued.
AI Teaches Brain Tumor Surgery Better Than Human Experts
𝙈𝙖𝙘𝙝𝙞𝙣𝙚 𝙡𝙚𝙖𝙧𝙣𝙞𝙣𝙜 𝙖𝙡𝙜𝙤𝙧𝙞𝙩𝙝𝙢𝙨 𝙚𝙣𝙝𝙖𝙣𝙘𝙚𝙙 𝙢𝙚𝙙𝙞𝙘𝙖𝙡 𝙨𝙩𝙪𝙙𝙚𝙣𝙩𝙨’ 𝙩𝙚𝙘𝙝𝙣𝙞𝙘𝙖𝙡 𝙥𝙚𝙧𝙛𝙤𝙧𝙢𝙖𝙣𝙘𝙚 𝙖𝙣𝙙 𝙡𝙚𝙖𝙧𝙣𝙞𝙣𝙜 𝙤𝙪𝙩𝙘𝙤𝙢𝙚𝙨 𝙙𝙪𝙧𝙞𝙣𝙜 𝙖 𝙨𝙞𝙢𝙪𝙡𝙖𝙩𝙚𝙙 𝙗𝙧𝙖𝙞𝙣 𝙩𝙪𝙢𝙤𝙧 𝙨𝙪𝙧𝙜𝙚𝙧𝙮, 𝙖 𝙣𝙚𝙬 𝙨𝙩𝙪𝙙𝙮 𝙨𝙝𝙤𝙬𝙨.
𝙏𝙝𝙚 𝘾𝙊𝙑𝙄𝘿-19 𝙥𝙖𝙣𝙙𝙚𝙢𝙞𝙘 𝙝𝙖𝙨 𝙥𝙧𝙚𝙨𝙚𝙣𝙩𝙚𝙙 𝙗𝙤𝙩𝙝 𝙘𝙝𝙖𝙡𝙡𝙚𝙣𝙜𝙚𝙨 𝙖𝙣𝙙 𝙤𝙥𝙥𝙤𝙧𝙩𝙪𝙣𝙞𝙩𝙞𝙚𝙨 𝙛𝙤𝙧 𝙢𝙚𝙙𝙞𝙘𝙖𝙡 𝙩𝙧𝙖𝙞𝙣𝙞𝙣𝙜. 𝙍𝙚𝙢𝙤𝙩𝙚 𝙡𝙚𝙖𝙧𝙣𝙞𝙣𝙜 𝙩𝙚𝙘𝙝𝙣𝙤𝙡𝙤𝙜𝙮 𝙝𝙖𝙨 𝙗𝙚𝙘𝙤𝙢𝙚 𝙞𝙣𝙘𝙧𝙚𝙖𝙨𝙞𝙣𝙜𝙡𝙮 𝙞𝙢𝙥𝙤𝙧𝙩𝙖𝙣𝙩 𝙞𝙣 𝙨𝙚𝙫𝙚𝙧𝙖𝙡 𝙛𝙞𝙚𝙡𝙙𝙨.
𝙏𝙝𝙚 𝙣𝙚𝙬 𝙨𝙩𝙪𝙙𝙮 𝙛𝙞𝙣𝙙𝙨 𝙩𝙝𝙖𝙩 𝙞𝙣 𝙖 𝙧𝙚𝙢𝙤𝙩𝙚 𝙚𝙣𝙫𝙞𝙧𝙤𝙣𝙢𝙚𝙣𝙩, 𝙖𝙣 𝙖𝙧𝙩𝙞𝙛𝙞𝙘𝙞𝙖𝙡 𝙞𝙣𝙩𝙚𝙡𝙡𝙞𝙜𝙚𝙣𝙘𝙚 (𝘼𝙄) 𝙩𝙪𝙩𝙤𝙧𝙞… See more.
The Neuro-Network.
𝐀𝐈 𝐓𝐞𝐚𝐜𝐡𝐞𝐬 𝐁𝐫𝐚𝐢𝐧 𝐓𝐮𝐦𝐨𝐫 𝐒𝐮𝐫𝐠𝐞𝐫𝐲 𝐁𝐞𝐭𝐭𝐞𝐫 𝐓𝐡𝐚𝐧 𝐇𝐮𝐦𝐚𝐧 𝐄𝐱𝐩𝐞𝐫𝐭𝐬
Artificial intelligence tutors are outperforming human instructors.
New Stanford Research Shows Differences Between Brains of Girls and Boys With Autism
Brain organization differs between boys and girls with autism, according to a new study from the Stanford University School of Medicine.
The differences, identified by analyzing hundreds of brain scans with artificial intelligence techniques, were unique to autism and not found in typically developing boys and girls. The research helps explain why autism symptoms differ between the sexes and may pave the way for better diagnostics for girls, according to the scientists.
Autism is a developmental disorder with a spectrum of severity. Affected children have social and communication deficits, show restricted interests and display repetitive behaviors. The original description of autism, published in 1943 by Leo Kanner, MD, was biased toward male patients. The disorder is diagnosed in four times as many boys as girls, and most autism research has focused on males.
New Chip Can Prevent Hackers From Extracting Hidden Information From Smart Devices
Engineers build a lower-energy chip that can prevent hackers from extracting hidden information from a smart device.
A heart attack patient, recently discharged from the hospital, is using a smartwatch to help monitor his electrocardiogram signals. The smartwatch may seem secure, but the neural network processing that health information is using private data that could still be stolen by a malicious agent through a side-channel attack.
A side-channel attack seeks to gather secret information by indirectly exploiting a system or its hardware. In one type of side-channel attack, a savvy hacker could monitor fluctuations in the device’s power consumption while the neural network is operating to extract protected information that “leaks” out of the device.